• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Xueli, ZHENG Xiao, LIU Yamin, SHAO Hua. Inhibition and mechanism of olanzapine on white adipose tissue beiging in mice[J]. Journal of China Pharmaceutical University, 2015, 46(6): 724-729. DOI: 10.11665/j.issn.1000-5048.20150615
Citation: ZHANG Xueli, ZHENG Xiao, LIU Yamin, SHAO Hua. Inhibition and mechanism of olanzapine on white adipose tissue beiging in mice[J]. Journal of China Pharmaceutical University, 2015, 46(6): 724-729. DOI: 10.11665/j.issn.1000-5048.20150615

Inhibition and mechanism of olanzapine on white adipose tissue beiging in mice

More Information
  • As one of the first-line antipsychotic drugs, olanzapine(OLA)inducing insulin resistance and metabolic disorder has become a serious clinical concern. This study aimed at investigating the effect of OLA on white adipose tissue(WAT)beiging as a potential mechanism behind its metabolism-disturbing effects. C57BL6/J mice were orally administered with low and high-dose OLA(4, 8 mg/kg, once daily)for 28 consecutive days; body weight and food intake were recorded every other day. Mice were subjected to glucose-tolerance test(GTT)and a cohort from each group was challenged with cold stress for 36 h before sacrifice. The perirenal, epididymal and inguinal WAT were carefully dissected, weighed and processed separately for hematoxylin-eosin staining, UCP-1 immunohistochemical and Western blot analysis. The results showed that OLA induced significant impairment in basal heat generation and glucose regulation. There were fewer beige adipocytes in the inguinal WAT after OLA treatment. The beiging of inguinal WAT in response to cold stress was significantly inhibited in OLA-treated mice. Mechanistically, OLA induced the activation of mTOR-Notch pathway, as evidenced by a significant increase in phosphorylated mammalian target of rapamycin(p-mTOR)and intracellular domain of Notch1(N1ICD)expression. Together, our study reveals that the inhibitory effects on WAT beiging may explain the propensity of OLA to induce metabolic disturbance, and mTOR-Notch pathway activation could play key roles in this effect. Future validation and elucidation of these novel findings are expected to provide novel insights into the metabolic risks of OLA and related second generation antipsychotics, which may lead to innovative intervention strategies in the clinic.
  • [1]
    Correll CU,Robinson DG,Schooler NR,et al.Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders:baseline results from the RAISE-ETP study[J].JAMA Psychiatry,2014,71(12):1350-1363.
    [2]
    Tiihonen J,Lonnqvist J,Wahlbeck K,et al.No mental health without physical health[J].Lancet,2011,377(9766):611.
    [3]
    Samaras K,Correll CU,Mitchell AJ,et al.Diabetes risk potentially underestimated in youth and children receiving antipsychotics[J].JAMA Psychiatry,2014,71(2):209-210.
    [4]
    Mizuno Y,Suzuki T,Nakagawa A,et al.Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia:a systematic review and meta-analysis[J].Schizophr Bull,2014,40(6):1385-1403.
    [5]
    Maayan L,Vakhrusheva J,Correll CU.Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities:a systematic review and meta-analysis[J].Neuropsychopharmacology,2010,35(7):1520-1530.
    [6]
    Ikegami M,Ikeda H,Ohashi T,et al.Olanzapine-induced hyperglycemia:possible involvement of histaminergic,dopaminergic and adrenergic functions in the central nervous system[J].Neuroendocrinology,2013,98(3):224-232.
    [7]
    Volpato AM,Zugno AI,Quevedo J.Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics[J].Rev Bras Psiquiatr,2013,35(3):295-304.
    [8]
    Cohen P,Levy JD,Zhang Y,et al.Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch[J].Cell,2014,156(1/2):304-316.
    [9]
    Rosenwald M,Perdikari A,Rulicke T,et al.Bi-directional interconversion of brite and white adipocytes[J].Nat Cell Biol,2013,15(6):659-667.
    [10]
    Dempersmier J,Sambeat A,Gulyaeva O,et al.Cold-inducible Zfp516 activates UCP1 transcription to promote browning of white fat and development of brown fat[J].Mol Cell,2015,57(2):235-246.
    [11]
    Blagosklonny MV. TOR-centric view on insulin resistance and diabetic complications:perspective for endocrinologists and gerontologists[J].Cell Death Dis,2013,4:e964.
    [12]
    Fukuda D,Aikawa E,Swirski FK,et al.Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders[J].Proc Natl Acad Sci U S A,2012,109(27):E1868-1877.
    [13]
    Bi P,Shan T,Liu W,et al.Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity[J].Nat Med,2014,20(8):911-918.
    [14]
    Bartelt A,Heeren J.Adipose tissue browning and metabolic health[J].Nat Rev Endocrinol,2014,10(1):24-36.
    [15]
    Pajvani UB,Qiang L,Kangsamaksin T,et al.Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability[J].Nat Med,2013,19(8):1054-1060.
    [16]
    Pajvani UB,Shawber CJ,Samuel VT,et al.Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner[J].Nat Med,2011,17(8):961-967.

Catalog

    Article views (1094) PDF downloads (1974) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return